Jessy Choi

ORCID: 0000-0002-1874-1953
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ocular Diseases and Behçet’s Syndrome
  • Autoimmune and Inflammatory Disorders Research
  • Systemic Lupus Erythematosus Research
  • Retinal and Optic Conditions
  • Ophthalmology and Eye Disorders
  • Glaucoma and retinal disorders
  • Ophthalmology and Visual Impairment Studies
  • Cytomegalovirus and herpesvirus research
  • Vaccine Coverage and Hesitancy
  • Retinal Diseases and Treatments
  • Immune responses and vaccinations
  • Otitis Media and Relapsing Polychondritis
  • Cerebral Venous Sinus Thrombosis
  • Immunodeficiency and Autoimmune Disorders
  • Urticaria and Related Conditions
  • Cerebrovascular and genetic disorders
  • COVID-19 and healthcare impacts
  • Osteoarthritis Treatment and Mechanisms
  • Retinal and Macular Surgery
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Infrared Thermography in Medicine
  • melanin and skin pigmentation
  • RNA regulation and disease
  • Ophthalmology and Visual Health Research
  • Inflammasome and immune disorders

Sheffield Children's NHS Foundation Trust
2015-2025

University of Sheffield
2015-2025

Sheffield Children's Hospital
2013-2025

Royal Hallamshire Hospital
2019-2024

Sheffield Teaching Hospitals NHS Foundation Trust
2018-2023

Royal Victoria Hospital
2023

University of Ulster
2023

University Hospital of Wales
2023

University College London
2023

Dewsbury and District Hospital
2013

10.1016/s2352-4642(20)30366-7 article EN The Lancet Child & Adolescent Health 2021-01-30

We aimed to provide, through the Uveitis in Childhood National Cohort Study, population-based evidence on incidence, distribution and disease characteristics for childhood onset non-infectious uveitis. Eligible children young people (<18 years) were those newly diagnosed with uveitis between 1 March 2020 28 February 2023. Cases identified recruited passive surveillance across a multicentre network. Descriptive analysis of demographic, socioeconomic clinical at diagnosis is reported alongside...

10.1136/bjo-2024-326674 article EN cc-by British Journal of Ophthalmology 2025-02-11

Background Adalimumab has demonstrated efficacy in non-infectious uveitis. With the introduction of biosimilar agents such as Amgevita, we aimed to quantify and tolerability compared Humira a multi-centre UK cohortMethods Patients identified from tertiary uveitis clinics 3 centres, after institution-mandated switching was implemented.Results Data collected for 102 patients, aged 2–75 years, with 185 active eyes. Following switch, rates flare were not significantly different (13 events...

10.1080/09273948.2023.2172591 article EN cc-by Ocular Immunology and Inflammation 2023-02-21

Gonioscopy-assisted transluminal trabeculotomy (GATT) is a minimally invasive ab interno procedure, performed with guidance of an illuminating microcatheter device (iTrack). The pathophysiology raised intraocular pressure (IOP) in uveitic glaucoma commonly due to increased resistance at the trabecular meshwork-Schlemm canal. By removing this resistance, GATT can potentially control IOP. In addition, approach avoids violating conjunctiva and reduces risk complications including infection,...

10.1097/ijg.0000000000001641 article EN cc-by Journal of Glaucoma 2020-08-21

Abstract Background Juvenile idiopathic arthritis (JIA)-associated uveitis is a chronic paediatric ocular inflammatory condition that can result in visual impairment. Adalimumab, tumour necrosis factor (TNF)-alpha inhibitor, effectively controls joint and eye inflammation; however, its long-term use may increase the risk of adverse health outcomes place an undue financial burden on patient healthcare system given high cost. There great interest for patients to stop adalimumab following...

10.1186/s13063-020-04796-z article EN cc-by Trials 2020-10-27

Aim: We describe the perceptions and experiences of healthcare services during pandemic those newly diagnosed with a rare, chronic eye disorder. Methods: A cross-sectional mixed-methods study nested within multi-center inception cohort study. Participants were UK families adolescents affected by childhood uveitis. Using validated tool (Health Foundation COVID-19 Survey), we captured quantitative (analyzed using descriptive statistics) qualitative content thematic analysis) data. Results:...

10.1080/23995270.2024.2366153 article EN cc-by-nc-nd Future Rare Diseases 2024-07-03
David Lim M J Todd N. Kourtoglou Konstantinos Gerasimidis Janet Gardner‐Medwin and 95 more L. Watson Kjell Tullus Clarissa Pilkington Christine Chesters Stephen D. Marks Paul Newland Caroline Jones Michael W. Beresford P. O'Neill H. Lee Rachel Tattersall Flora McErlane Michael W. Beresford Eileen Baildam S. E. Alice Chieng Joyce Davidson Helen Foster Janet Gardner‐Medwin Mark Lunt Lucy R. Wedderburn Wendy Thomson Kimme L Hyrich Akhila Kavirayani Manigandan Thyagarajan Jane Ellis C. N. S. Helen Strike Athimalaipet V Ramanan Andrea Coda Joyce Davidson Peter W Fowlie Joe Walsh Tom Carline Derek Santos K. W. Brimlow S Rangaraj Caroline Grant Jessica Little C. N. S. Helen Strike Annie Hinchcliffe Andrew D. Dick Athimalaipet V Ramanan D. Ekdawy G. Nagra Nikki Camina Jenny Edgerton Jessy Choi K. Lamb Daniel Hawley S Rangaraj M. Cruikshank Ethan S. Sen Clare Pain Valentina Leone M. Cruikshank Joe Walsh Rachel Tattersall Daniel Hawley Lisa Dunkley H. Lee Anne-Marie McMahon Peter Bale Kate Armon T. Amin Mark Wood Rebecca Davies T. R. Southwood Lianne Kearsley‐Fleet Kimme L Hyrich Lianne Kearsley‐Fleet Eileen Baildam Michael W. Beresford Rebecca Davies Helen Foster K. Mowbray T. R. Southwood Wendy Thomson Kimme L Hyrich M. Agarwal Akhila Kavirayani Athimalaipet V Ramanan Jane Ellis Eve Smith William K. Gray David Taylor‐Robinson Helen Foster Michael W. Beresford Thomas D. Morgan L. Watson Michael W. Beresford Faekah Gohar L. Watson Michael W. Beresford Ethan S. Sen Anna Radziszewska Charis Pericleous

Background: Development of modern therapeutic approaches over the last decade has improved short-term well-being in JIA patients. This study examines disease damage and body composition (BC). Aims: Comparison patients’ clinical with matched controls assessing BC, cross-sectional inflammatory markers levels joint uveitis-associated relating to their management. Methods: 112 patients (disease duration ≥5 years) were cross-sectionally compared 127 age, sex, ethnicity deprivation score-matched...

10.1093/rheumatology/ket116 article EN Lara D. Veeken 2012-12-01

The Sheffield Virtual Adult Strabismus service was already well established and put to real-time trial during the COVID-19 pandemic. We describe a multi-disciplinary adaptation offer safe effective delivery. evaluate efficacy of virtual strabismus pandemic meet clinical demand, streamline patient care, balance care delivery optimise medical input.Prospective data analysis from clinics dated January 2015 November 2021. All information captured at first consultation with comprehensive...

10.22599/bioj.273 article EN cc-by British and Irish Orthoptic Journal 2022-01-01

Background: A joint paediatric-adult uveitis transition clinic has recently been established in Sheffield involving staff from the Children's NHS Foundation Trust and Teaching Hospitals Trust.Children adults with are managed using similar treatment strategies encompassing a combination of MTX, MMF biologic treatments.We conducted service evaluation to describe response individuals receiving therapy: MTX MMF.Here we report data paediatric service.Aims: To document pathway for children young...

10.1093/rheumatology/keu512 article EN Lara D. Veeken 2015-05-01

10.1016/j.jaapos.2016.07.109 article EN Journal of American Association for Pediatric Ophthalmology and Strabismus 2016-08-01
Coming Soon ...